Text or call a human:Text (808) 600-9260Call
CorporateVentureCapital.com

Loftyrock Investment

Profile and portfolio

Parent Dongkoo Bio & PharmaHQ South KoreaFounded 2022

Loftyrock Investment is the corporate venture arm of Dongkoo Bio & Pharma, a pharmaceutical and biotech company. It was founded in 2022 and is based in South Korea. It invests from seed to Series A. Sectors it names: healthcare and digital health, biotech and life sciences.

Every figure links to its source

Snapshot

Investment stage: Seed to Series A
Data behind this graphic
Data behind this graphic
ItemValue
Stage rangeSeed to Series A
SectorsHealthcare and digital health, Biotech and life sciences
GeographyNorth America, Asia

Sources: S1 Pharmnews: Dongkoo Bio & Pharma subsidiary Loftyrock enters capital markets (2022-02-08).

Graphic 1 of 1

Investment stage: Seed to Series A

Sources: S1 Pharmnews: Dongkoo Bio & Pharma subsidiary Loftyrock enters capital markets (2022-02-08).

Download:Report a correction

Where it invests and who leads it

Geography

Headquarters
South Korea

Investment regionsS1

LeadersS1

Loftyrock Investment on LinkedIn

Key facts

FactValueStatusSource
Parent companyDongkoo Bio & PharmaSingle sourceS1
Parent industryPharmaceuticals and biotechSingle sourceS1
Founded2022Single sourceS1
HeadquartersSouth KoreaSingle sourceS1
StatusActiveSingle sourceS1
Capital sourceParent company onlySingle sourceS1
StagesSeed, Series A (inferred from announced rounds)EstimateS1

Fund vehicles

VehicleSizeYearSource
Dongkoo Bio-Welcome New Technology Business Investment Partnership No. 1Not published2022S1

Recent rounds

DateCompanyRoundAmountSource
2022-02-08Valted SeqNot statedKRW 3bnS1
2022-02-08ZigbangNot statedKRW 2bnS1

Portfolio

Public sources name 5 portfolio companies.S1

Shared portfolio with other corporate VCs

1 companies on the Loftyrock Investment portfolio page also appear on the portfolio page of at least one other firm in this directory. Matched by company website, or by name where no website is published.

FirmSharedCompanies in common
CKD Venture Capital1Fin Therapeutics

Companies backed by the most corporate VCs

Every company on the Loftyrock Investment list

5 companies, as named in the sources cited.S1 Read the firm's list.

  • AMCG
  • CARV
  • Fin Therapeutics
  • Valted Seq
  • Zigbang

Sources

  1. S1Pharmnews: Dongkoo Bio & Pharma subsidiary Loftyrock enters capital markets (2022-02-08)Press

Disclaimer and corrections

Not affiliated. This page is not affiliated with, endorsed by or sponsored by Loftyrock Investment or any company named on it. Names and trademarks belong to their owners. Informational only. This is a public-source reference. It is not investment, legal or tax advice and not an offer or solicitation. Sources. Each figure names its source. Figures may have changed. Please read the firm's official pages, linked above. Corrections and takedown. To report an error or ask for a change or removal, use the correction form or email Richard@CorporateVentureCapital.com.

Spotted a mistake? Report a correction.